• About
CMM
Karolinska institutet
Karolinska universitetssjukhuset
Sök

Marina Galesic, recipient of the 2026 Cilla Weigelt Award

Marina Galesic, a PhD student at Karolinska Institutet and part of Begum Horuluoglu’s team at CMM, receives the Cilla Weigelt Award 2026 for her research into rare and serious autoimmune diseases. These are conditions in which the immune system mistakenly attacks the body’s own tissues.

Her work focuses on anti-MDA5-positive dermatomyositis, a severe disease that can quickly damage the lungs and may be fatal despite intensive treatment.

Marina has developed new tools to study how certain antibodies may contribute to tissue damage. She is also investigating how CAR T-cell therapy affects the immune system in people with muscle inflammation. Her research could help improve treatments for autoimmune diseases in the future.

The Cilla Weigelt award aims to encourage and support PhD students investigating molecular mechanisms of relevance to rare and undertreated diseases. Cilla Weigelt passed away in 2021 at the age of 51, after living ten years with breast cancer. The Award has been established by Chiesi (her employer), the Structural Genomics Consortium (SGC) and by friends and family, in her spirit, to support and inspire young PhD students and to honor her memory.

The award ceremony will take place on November 23 at Chiesi R&D in Solna.

Congratulations, Marina!

This text is based on a post from Chiesi.

About CMM

The Center for Molecular Medicine (CMM) is a foundation instituted by the Stockholm County Council (Region Stockholm). CMM is at the heart of a close partnership with the Karolinska University Hospital and Karolinska Institutet, fueling advancements in biomedical and clinical research.

Contact

Center for Molecular Medicine Foundation, org. nr. 815201-3689

Karolinska University Hospital L8:05

Visionsgatan 18

171 76 Stockholm, Sweden

communication@cmm.se

CMM
Karolinska institutet
Karolinska universitetssjukhuset